Hyperkalemia Completed Phase 1 Trials for Tacrolimus (DB00864)

Also known as: Hyperkalemia (HK) / Hyperkalaemia / Hyperpotassaemia / Hyperpotassemia / Potassium overload / Potassium [K] excess

Indication	Status	Phase
DBCOND0003949 (Hyperkalemia)	Completed	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04788641	Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects	Treatment	Cyclosporine (DB00091) Sodium zirconium cyclosilicate (DB14048) Tacrolimus (DB00864)